Lang Li

509 total citations
28 papers, 413 citations indexed

About

Lang Li is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Lang Li has authored 28 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Cardiology and Cardiovascular Medicine and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Lang Li's work include Cardiac Imaging and Diagnostics (8 papers), Inflammasome and immune disorders (6 papers) and Cardiac Ischemia and Reperfusion (5 papers). Lang Li is often cited by papers focused on Cardiac Imaging and Diagnostics (8 papers), Inflammasome and immune disorders (6 papers) and Cardiac Ischemia and Reperfusion (5 papers). Lang Li collaborates with scholars based in China and United States. Lang Li's co-authors include Qiang Su, Yangchun Liu, Yuhan Sun, Haoliang Li, Huafeng Yang, Tao Liu, Xiantao Wang, Jinmin Zhao, Zhiqing Chen and Tao Li and has published in prestigious journals such as PLoS ONE, Journal of Cellular Biochemistry and International Journal of Cardiology.

In The Last Decade

Lang Li

28 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lang Li China 14 201 128 76 72 66 28 413
Hongyang Shu China 13 222 1.1× 174 1.4× 53 0.7× 72 1.0× 48 0.7× 23 528
Hong Zhi China 15 214 1.1× 127 1.0× 129 1.7× 38 0.5× 35 0.5× 34 499
Ilayaraja Muthuramu Belgium 16 183 0.9× 264 2.1× 38 0.5× 62 0.9× 33 0.5× 28 529
Kazutoshi Mawatari Japan 9 107 0.5× 121 0.9× 26 0.3× 67 0.9× 37 0.6× 22 346
Shanhong Lu China 13 254 1.3× 93 0.7× 132 1.7× 27 0.4× 48 0.7× 24 647
Shujian Wei China 11 183 0.9× 86 0.7× 88 1.2× 119 1.7× 62 0.9× 22 488
Guoxin Tong China 11 120 0.6× 105 0.8× 69 0.9× 22 0.3× 43 0.7× 34 326
Arihiro Sumida Japan 8 219 1.1× 285 2.2× 70 0.9× 29 0.4× 112 1.7× 13 671
Wanting Shi China 11 263 1.3× 120 0.9× 76 1.0× 51 0.7× 49 0.7× 30 555

Countries citing papers authored by Lang Li

Since Specialization
Citations

This map shows the geographic impact of Lang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lang Li more than expected).

Fields of papers citing papers by Lang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lang Li. The network helps show where Lang Li may publish in the future.

Co-authorship network of co-authors of Lang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Lang Li. A scholar is included among the top collaborators of Lang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lang Li. Lang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Tao, et al.. (2025). Vericiguat reduces pyroptosis in rats with coronary microembolization by inhibiting the AMPK/Nrf2/NLRP3 signaling pathway. Korean Journal of Physiology and Pharmacology. 29(6). 755–767. 1 indexed citations
2.
Li, Hongqing, Huafeng Yang, Zhenbai Qin, Qiang Wang, & Lang Li. (2024). Colchicine ameliorates myocardial injury induced by coronary microembolization through suppressing pyroptosis via the AMPK/SIRT1/NLRP3 signaling pathway. BMC Cardiovascular Disorders. 24(1). 23–23. 13 indexed citations
3.
4.
Li, Haoliang, et al.. (2022). Tanshinone IIA reduces pyroptosis in rats with coronary microembolization by inhibiting the TLR4/MyD88/NF-κB/NLRP3 pathway. Korean Journal of Physiology and Pharmacology. 26(5). 335–345. 11 indexed citations
5.
Li, Tao, et al.. (2021). Resveratrol Pretreatment Inhibits Myocardial Apoptosis in Rats Following Coronary Microembolization via Inducing the PI3K/Akt/GSK-3β Signaling Cascade. Drug Design Development and Therapy. Volume 15. 3821–3834. 15 indexed citations
6.
Chen, Zhiqing, Feng Chen, Junwen Huang, et al.. (2021). miR-200a-3p Attenuates Coronary Microembolization-Induced Myocardial Injury in Rats by Inhibiting TXNIP/NLRP3-Mediated Cardiomyocyte Pyroptosis. Frontiers in Cardiovascular Medicine. 8. 693257–693257. 22 indexed citations
7.
Kong, Binghui, et al.. (2019). microRNA‐26a‐5p affects myocardial injury induced by coronary microembolization by modulating HMGA1. Journal of Cellular Biochemistry. 120(6). 10756–10766. 20 indexed citations
8.
9.
Su, Qiang, Lang Li, Jinmin Zhao, Yuhan Sun, & Huafeng Yang. (2017). MiRNA Expression Profile of the Myocardial Tissue of Pigs with Coronary Microembolization. Cellular Physiology and Biochemistry. 43(3). 1012–1024. 20 indexed citations
10.
Li, Lang, et al.. (2017). The protective effect of activating Nrf2 / HO-1 signaling pathway on cardiomyocyte apoptosis after coronary microembolization in rats. BMC Cardiovascular Disorders. 17(1). 272–272. 22 indexed citations
11.
Su, Qiang, Lang Li, Jinmin Zhao, Yuhan Sun, & Huafeng Yang. (2017). Effects of Trimetazidine on PDCD4/NF-κB/TNF-α Pathway in Coronary Microembolization. Cellular Physiology and Biochemistry. 42(2). 753–760. 21 indexed citations
12.
Chen, Han, et al.. (2017). Levosimendan Pretreatment Inhibits Myocardial Apoptosis in Swine after Coronary Microembolization. Cellular Physiology and Biochemistry. 41(1). 67–78. 8 indexed citations
13.
Zeng, Zhiyu, Chun Gui, Lang Li, & Xiaomin Wei. (2016). Effects of Percutaneous Coronary Intervention on Serum Angiopoietin-2 in Patients with Coronary Heart Disease. Chinese Medical Journal. 129(6). 631–635. 12 indexed citations
14.
Chen, Han, et al.. (2016). The PTEN/Akt Signaling Pathway Mediates Myocardial Apoptosis in Swine After Coronary Microembolization. Journal of Cardiovascular Pharmacology and Therapeutics. 21(5). 471–477. 16 indexed citations
15.
Liu, Tao, et al.. (2015). Coronary Microembolization Induces Cardiomyocyte Apoptosis Through the LOX-1–Dependent Endoplasmic Reticulum Stress Pathway Involving JNK/P38 MAPK. Canadian Journal of Cardiology. 31(10). 1272–1281. 36 indexed citations
16.
Li, Lang, et al.. (2014). The Involvement of Phosphatase and Tensin Homolog Deleted on Chromosome Ten (PTEN) in the Regulation of Inflammation Following Coronary Microembolization. Cellular Physiology and Biochemistry. 33(6). 1963–1974. 15 indexed citations
17.
Hocevar, Barbara A., Lisa M. Kamendulis, Xinzhu Pu, et al.. (2014). Contribution of Environment and Genetics to Pancreatic Cancer Susceptibility. PLoS ONE. 9(3). e90052–e90052. 12 indexed citations
18.
Su, Qiang, et al.. (2013). Effect of metoprolol on myocardial apoptosis after coronary microembolization in rats. World Journal of Emergency Medicine. 4(2). 138–138. 4 indexed citations
19.
Li, Lang, et al.. (2013). Endothelial microparticles exert differential effects on functions of Th1 in patients with acute coronary syndrome. International Journal of Cardiology. 168(6). 5396–5404. 33 indexed citations
20.
Wú, Xiànghóng & Lang Li. (2011). Rosiglitazone suppresses lipopolysaccharide-induced matrix metalloproteinase-2 activity in rat aortic endothelial cells via Ras-MEK1/2 signaling. International Journal of Cardiology. 158(1). 54–58. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongyang Shu Breakdown of academic impact, for papers by Hong Zhi Breakdown of academic impact, for papers by Ilayaraja Muthuramu Breakdown of academic impact, for papers by Kazutoshi Mawatari Breakdown of academic impact, for papers by Shanhong Lu Breakdown of academic impact, for papers by Shujian Wei Breakdown of academic impact, for papers by Guoxin Tong Breakdown of academic impact, for papers by Arihiro Sumida Breakdown of academic impact, for papers by Wanting Shi
Rankless by CCL
2026